Measuring the clinical response. What does it mean?
- 1 September 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (14), 1817-1823
- https://doi.org/10.1016/s0959-8049(02)00182-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Response rates, survival, and chemotherapy trials.JNCI Journal of the National Cancer Institute, 2000
- A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.JNCI Journal of the National Cancer Institute, 2000
- Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysisThe Lancet, 2000
- The Pursuit of Optimal Outcomes in Cancer Therapy in a New Age of Rationally Designed Target-Based Anticancer AgentsDrugs, 2000
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Statistical Model to Determine the Relationship of Response and Survival in Patients With Advanced Ovarian Cancer Treated With ChemotherapyJNCI Journal of the National Cancer Institute, 1992
- Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trialsControlled Clinical Trials, 1983
- Reporting results of cancer treatmentCancer, 1981
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960